{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:49:07Z","timestamp":1787003347597,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T00:00:00Z","timestamp":1506384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T00:00:00Z","timestamp":1506384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Liver disease in HIV-infected patients may result from the infection itself, antiretroviral treatment or comorbidities. In this study, we analysed liver disease in 79 HIV-infected children and adolescents aged 14.0\u2009\u00b1\u20095.1 years. All the patients were receiving combination antiretroviral therapy (cART), with a mean duration of 11.5\u2009\u00b1\u20094.7 years. Six patients (8%) had detectable HIV viral load, and 8\/79 (10%) of the participants were coinfected with hepatitis B or C virus (HCV, 6\/8 or HBV, 2\/8). Liver disease was defined as an elevation of any of the following parameters: alanine or aspartate aminotransferase (ALT and AST), total bilirubin, and gamma glutamyl transferase (GGTP). For the noninvasive evaluation of liver fibrosis, the AST-to-Platelet Ratio Index (APRI) and Fibrosis-4 (FIB-4) were calculated. Liver disease was diagnosed in 20\/79 (25%) of the patients, including 13\/71 (18%) of participants without coinfection and 7\/8 (88%) with coinfection (p\u2009&lt;\u20090.0001). All of the liver markers except bilirubin were significantly higher in the coinfected group. APRI scores indicated significant fibrosis in 5\/8 (63%) of patients with coinfection. HBV or HCV coinfection and detectable HIV viral load were independently positively associated with APRI (p\u2009=\u20090.0001, and p\u2009=\u20090.0001) and FIB-4 (p\u2009=\u20090.001, and p\u2009=\u20090.002, respectively). In conclusion, liver disease in HIV-infected children and adolescents results mainly from HBV or HCV coinfection. Effective antiretroviral treatment is protective against hepatic abnormalities.<\/jats:p>","DOI":"10.1038\/s41598-017-11489-2","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T04:50:44Z","timestamp":1505883044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prevalence and predictors of liver disease in HIV-infected children and adolescents"],"prefix":"10.1038","volume":"7","author":[{"given":"Maria","family":"Pokorska-\u015apiewak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Sta\u0144ska-Perka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Popielska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"O\u0142dakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Coupland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Zawadka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Szczepa\u0144ska-Putz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Marczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,26]]},"reference":[{"key":"11489_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","volume":"43","author":"FJ Palella","year":"2006","unstructured":"Palella, F. J. et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr \n                           43, 27\u201334, doi:10.1097\/01.qai.0000233310.90484.16 (2006).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"11489_CR2","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1097\/QAD.0b013e32833c7b9c","volume":"24","author":"C Smith","year":"2010","unstructured":"Smith, C. et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS \n                           24, 1537\u20131548, doi:10.1097\/QAD.0b013e32833a0918 (2010).","journal-title":"AIDS"},{"key":"11489_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/QAI.0b013e3181b9869f","volume":"53","author":"MT Brady","year":"2010","unstructured":"Brady, M. T. et al. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr \n                           53, 86\u201394, doi:10.1097\/QAI.0b013e3181b9869f (2010).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"11489_CR4","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.cgh.2010.08.024","volume":"8","author":"JC Price","year":"2010","unstructured":"Price, J. C. & Thio, C. L. Liver disease in the HIV-infected individual. Clin Gastroenterol Hepatol \n                           8, 1002\u20131012, doi:10.1016\/j.cgh.2010.08.024 (2010).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11489_CR5","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1097\/INF.0000000000000693","volume":"34","author":"L Aurpibul","year":"2015","unstructured":"Aurpibul, L. et al. Prevalence and incidence of liver dysfunction and assessment of biomarkers of liver disease in HIV-infected Asian children. Pediatr Infect Dis J \n                           34, e153\u2013158, doi:10.1097\/INF.0000000000000693 (2015).","journal-title":"Pediatr Infect Dis J"},{"key":"11489_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/QAD.0000000000001003","volume":"30","author":"BG Kapogiannis","year":"2016","unstructured":"Kapogiannis, B. G. et al. Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth. AIDS \n                           30, 889\u2013898, doi:10.1097\/QAD.0000000000001003 (2016).","journal-title":"AIDS"},{"key":"11489_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/gut.2008.163287","volume":"59","author":"R Bruno","year":"2010","unstructured":"Bruno, R. et al. gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. Gut \n                           59, 513\u2013520, doi:10.1136\/gut.2008.163287 (2010).","journal-title":"Gut"},{"key":"11489_CR8","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1086\/378643","volume":"188","author":"N Munshi","year":"2003","unstructured":"Munshi, N., Balasubramanian, A., Koziel, M., Ganju, R. K. & Groopman, J. E. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis \n                           188, 1192\u20131204, doi:10.1086\/378643 (2003).","journal-title":"J Infect Dis"},{"key":"11489_CR9","first-page":"1","volume":"86","author":"MS Cappell","year":"1991","unstructured":"Cappell, M. S. Hepatobiliary manifestations of the acquired immune deficiency syndrome. Am J Gastroenterol \n                           86, 1\u201315 (1991).","journal-title":"Am J Gastroenterol"},{"key":"11489_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000171468","volume":"12","author":"JH Lefkowitch","year":"1994","unstructured":"Lefkowitch, J. H. Pathology of AIDS-related liver disease. Dig Dis \n                           12, 321\u2013330 (1994).","journal-title":"Dig Dis"},{"issue":"Suppl 2","key":"11489_CR11","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1086\/381499","volume":"38","author":"S Pol","year":"2004","unstructured":"Pol, S., Lebray, P. & Vallet-Pichard, A. HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms. Clin Infect Dis \n                           38(Suppl 2), S65\u201372, doi:10.1086\/381499 (2004).","journal-title":"Clin Infect Dis"},{"key":"11489_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cgh.2009.09.025","volume":"8","author":"N Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone, N. et al. Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons. Clin Gastroenterol Hepatol \n                           8, 183\u2013191, doi:10.1016\/j.cgh.2009.09.025 (2010).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11489_CR13","doi-asserted-by":"publisher","unstructured":"Dezsofi, A. et al. Liver Biopsy in Children: Position Paper of the ESPGHAN Hepatology Committee. Journal of pediatric gastroenterology and nutrition, doi:10.1097\/MPG.0000000000000632 (2014).","DOI":"10.1097\/MPG.0000000000000632"},{"key":"11489_CR14","doi-asserted-by":"publisher","first-page":"12141","DOI":"10.3748\/wjg.v21.i42.12141","volume":"21","author":"M Pokorska-\u015apiewak","year":"2015","unstructured":"Pokorska-\u015apiewak, M., Kowalik-Miko\u0142ajewska, B., Aniszewska, M., Pluta, M. & Marczy\u0144ska, M. Is liver biopsy still needed in children with chronic viral hepatitis? World J Gastroenterol \n                           21, 12141\u201312149, doi:10.3748\/wjg.v21.i42.12141 (2015).","journal-title":"World J Gastroenterol"},{"key":"11489_CR15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","volume":"142","author":"L Castera","year":"2012","unstructured":"Castera, L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology \n                           142, 1293\u20131302.e1294, doi:10.1053\/j.gastro.2012.02.017 (2012).","journal-title":"Gastroenterology"},{"key":"11489_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/INF.0000000000000348","volume":"33","author":"GK Siberry","year":"2014","unstructured":"Siberry, G. K. et al. Elevated aspartate aminotransferase-to-platelet ratio index in perinatally HIV-infected children in the United States. Pediatr Infect Dis J \n                           33, 855\u2013857, doi:10.1097\/INF.0000000000000348 (2014).","journal-title":"Pediatr Infect Dis J"},{"key":"11489_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/INF.0b013e3182a01dfb","volume":"33","author":"GK Siberry","year":"2014","unstructured":"Siberry, G. K. et al. Prevalence and predictors of elevated aspartate aminotransferase-to-platelet ratio index in Latin American perinatally HIV-infected children. Pediatr Infect Dis J \n                           33, 177\u2013182, doi:10.1097\/INF.0b013e3182a01dfb (2014).","journal-title":"Pediatr Infect Dis J"},{"key":"11489_CR18","unstructured":"WHO recommendations on the diagnosis of HIV infection in infants and children. World Health Organisation, Available at http:\/\/apps.who.int\/iris\/bitstream\/10665\/44275\/1\/9789241599085_eng.pdf. Accessed 2017\/03\/06 (2010)."},{"key":"11489_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai, C. T. et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology \n                           38, 518\u2013526, doi:10.1053\/jhep.2003.50346 (2003).","journal-title":"Hepatology"},{"key":"11489_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology (Baltimore, Md.) \n                           43, 1317\u20131325, doi:10.1002\/hep.21178 (2006).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"11489_CR21","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/hep.24105","volume":"53","author":"ZH Lin","year":"2011","unstructured":"Lin, Z. H. et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology (Baltimore, Md.) \n                           53, 726\u2013736, doi:10.1002\/hep.24105 (2011).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"#cr-split#-11489_CR22.1","unstructured":"Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age"},{"key":"#cr-split#-11489_CR22.2","unstructured":"Official authorized addenda: human immunodeficiency virus infection codes and official guidelines for coding and reporting ICD-9-CM. MMWR 43(No.RR-12) (1994)."},{"key":"11489_CR23","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","volume":"166","author":"R Weber","year":"2006","unstructured":"Weber, R. et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med \n                           166, 1632\u20131641, doi:10.1001\/archinte.166.15.1632 (2006).","journal-title":"Arch Intern Med"},{"key":"11489_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1586\/eri.13.2","volume":"11","author":"SA Healy","year":"2013","unstructured":"Healy, S. A., Gupta, S. & Melvin, A. J. HIV\/HBV coinfection in children and antiviral therapy. Expert Rev Anti Infect Ther \n                           11, 251\u2013263, doi:10.1586\/eri.13.2 (2013).","journal-title":"Expert Rev Anti Infect Ther"},{"key":"11489_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/QAD.0000000000001285","volume":"31","author":"EPHC-ISGITEPAPHCCEI EuroCoord","year":"2017","unstructured":"EuroCoord, E. P. H. C.-I. S. G. I. T. E. P. A. P. H. C. C. E. I. Coinfection with HIV and hepatitis C virus in 229 children and young adults living in Europe. AIDS \n                           31, 127\u2013135, doi:10.1097\/QAD.0000000000001285 (2017).","journal-title":"AIDS"},{"key":"11489_CR26","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/hep.510290447","volume":"29","author":"JF Colin","year":"1999","unstructured":"Colin, J. F. et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology \n                           29, 1306\u20131310, doi:10.1002\/hep.510290447 (1999).","journal-title":"Hepatology"},{"issue":"9","key":"11489_CR27","volume":"15","author":"CL Thio","year":"2003","unstructured":"Thio, C. L. Treatment of chronic hepatitis B in the HIV-infected patient. Hopkins HIV Rep \n                           15(9), 12 (2003).","journal-title":"Hopkins HIV Rep"},{"key":"11489_CR28","first-page":"25","volume":"15","author":"V Soriano","year":"2013","unstructured":"Soriano, V., Barreiro, P. & Sherman, K. E. The changing epidemiology of liver disease in HIV patients. AIDS Rev \n                           15, 25\u201331 (2013).","journal-title":"AIDS Rev"},{"key":"11489_CR29","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1086\/587843","volume":"197","author":"M Danta","year":"2008","unstructured":"Danta, M. et al. Impact of HIV on host-virus interactions during early hepatitis C virus infection. J Infect Dis \n                           197, 1558\u20131566, doi:10.1086\/587843 (2008).","journal-title":"J Infect Dis"},{"key":"11489_CR30","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/S0140-6736(00)03232-3","volume":"356","author":"G Greub","year":"2000","unstructured":"Greub, G. et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet \n                           356, 1800\u20131805 (2000).","journal-title":"Lancet"},{"key":"11489_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-8278(97)80001-3","volume":"26","author":"B Soto","year":"1997","unstructured":"Soto, B. et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol \n                           26, 1\u20135 (1997).","journal-title":"J Hepatol"},{"key":"11489_CR32","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1086\/321909","volume":"33","author":"CS Graham","year":"2001","unstructured":"Graham, C. S. et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis \n                           33, 562\u2013569, doi:10.1086\/321909 (2001).","journal-title":"Clin Infect Dis"},{"key":"11489_CR33","doi-asserted-by":"crossref","unstructured":"European Paediatric Hepatitis, C. V. N. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America \n                           41, 45\u201351, doi:CID35334 [pii] (2005).","DOI":"10.1086\/430601"},{"key":"11489_CR34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00126334-200312010-00004","volume":"34","author":"RB Reisler","year":"2003","unstructured":"Reisler, R. B., Han, C., Burman, W. J., Tedaldi, E. M. & Neaton, J. D. Grade 4 events are as important as AIDS events in the era of HAART. J Acquir Immune Defic Syndr \n                           34, 379\u2013386 (2003).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"11489_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jama.283.1.74","volume":"283","author":"MS Sulkowski","year":"2000","unstructured":"Sulkowski, M. S., Thomas, D. L., Chaisson, R. E. & Moore, R. D. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA \n                           283, 74\u201380 (2000).","journal-title":"JAMA"},{"issue":"Suppl 2","key":"11489_CR36","first-page":"S24","volume":"3","author":"B McGovern","year":"2004","unstructured":"McGovern, B. Hepatic safety and HAART. J Int Assoc Physicians AIDS Care (Chic) \n                           3(Suppl 2), S24\u201340 (2004).","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11489-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11489-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11489-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T06:22:44Z","timestamp":1671776564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11489-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,26]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["11489"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-11489-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,26]]},"assertion":[{"value":"5 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12309"}}